Medina-Echeverz, J., Hinterberger, M., Testori, M., Geiger, M., Giessel, R., Bathke, B., . . . Lauterbach, H. (2019). Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies. Nat Commun.
Chicago Stili AlıntıMedina-Echeverz, José, et al. "Synergistic Cancer Immunotherapy Combines MVA-CD40L Induced Innate and Adaptive Immunity With Tumor Targeting Antibodies." Nat Commun 2019.
MLA AlıntıMedina-Echeverz, José, et al. "Synergistic Cancer Immunotherapy Combines MVA-CD40L Induced Innate and Adaptive Immunity With Tumor Targeting Antibodies." Nat Commun 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..